Tilray Brands Inc. Cl 2 (TLRY): Price and Financial Metrics
GET POWR RATINGS... FREE!
TLRY Stock Price Chart Interactive Chart >
TLRY Price/Volume Stats
| Current price | $3.11 | 52-week high | $17.91 |
| Prev. close | $3.12 | 52-week low | $3.02 |
| Day low | $3.06 | Volume | 5,739,501 |
| Day high | $3.22 | Avg. volume | 28,986,113 |
| 50-day MA | $4.24 | Dividend yield | N/A |
| 200-day MA | $7.28 | Market Cap | 1.55B |
Tilray Brands Inc. Cl 2 (TLRY) Company Bio
Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. was founded in 2018 and is based in Nanaimo, Canada.
Latest TLRY News From Around the Web
Below are the latest news stories about Tilray Brands Inc that investors may wish to consider to help them evaluate TLRY as an investment opportunity.
Tilray Stock Forecast 2025: Where Are Shares Of The Cannabis Co. Headed?Tilray Inc (NASDAQ: TLRY ), a Canadian pharmaceutical and cannabis company, is one of the most popular cannabis stocks out there . Back in 2018, the stock ran all the way to $148 before coming back down to the single digits. So where will … Full story available on Benzinga.com |
Where Will Tilray''s Stock Be In 2025? Survey Says...Tilray Inc (NASDAQ: TLRY ), a Canadian pharmaceutical and cannabis company, is one of the most popular cannabis stocks out there . Back in 2018, the stock ran all the way to $148 before coming back down to the single digits. So where will … Full story available on Benzinga.com |
Will Tilray Hold Its Own in 2022?Tilray (TLRY) used to be a top Canadian cannabis producer after entering into a reverse acquisition with rival Aphria. The company had the dual advantage of being more diverse and having its operations spread across multiple places in the world. This was unlike most other pot producers in the United States. It was even termed as a Global Cannabis leader. However, last year, Tilray lost over 80% of its value. The legalization of marijuana in the United States might open up more avenues for the company in the coming days, but there is no certainty of its happening. |
Is it Finally SAFE to Invest in Tilray Stock?The SAFE Banking Act may be the catalyst that long-suffering investors in TLRY stock have been waiting for, but it pales in comparison to legalization. |
Cannabis Movers & Shakers: MedMen, Organigram, NeonMind, Green Check VerifiedFormer Tilray Exec Ana Bowman Joins MedMen As CFO MedMen Enterprises Inc . (CSE: MMEN) (OTCQX: MMNFF ) has appointed Ana Bowman as a chief financial officer, effective February 22. Bowman will succeed outgoing interim CFO Reece Fulgham, who will be returning to consulting firm SierraConstellation Partners. Bowman brings years of cannabis industry expertise, having served as vice president of financial reporting and FP&A of Tilray Brands (NASDAQ: TLRY ) (TSX:TLRY). Prior to joining Tilray, Bowman served as corporate controller of several publicly-traded U.S. registrants, following an exit from the world of big four public accounting. "We are excited to have Ana join as our permanent CFO — bringing with her significant financial expertise from her time at Tilray and large public accountin... |
TLRY Price Returns
| 1-mo | -25.60% |
| 3-mo | -58.42% |
| 6-mo | -55.76% |
| 1-year | -82.56% |
| 3-year | -93.44% |
| 5-year | N/A |
| YTD | -55.76% |
| 2021 | -14.89% |
| 2020 | -51.78% |
| 2019 | -75.72% |
| 2018 | N/A |
| 2017 | N/A |
Continue Researching TLRY
Want to see what other sources are saying about Tilray Inc's financials and stock price? Try the links below:Tilray Inc (TLRY) Stock Price | Nasdaq
Tilray Inc (TLRY) Stock Quote, History and News - Yahoo Finance
Tilray Inc (TLRY) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...